Wolf C, Ehrig C, Brunner H
Schweiz Med Wochenschr. 1981 Mar 7;111(10):343-7.
In 25 patients with chronic exocrine pancreatic insufficiency and 37 controls, the PABA test was compared with the concentration of chymotrypsin in stool. In additional 16 patients the test could not be evaluated (rate 21%). By determination of the PABA levels in serum before and one hour after ingestion of N-benzoyl-L-tyrosyl-PABA the test can be shortened and simplified: 1 hour serum levels in 9 patients with exocrine pancreatic insufficiency were 0.5 +/- 0.5 nMol/ml compared with 8 controls with 6.4 +/- 2.0 nMol/ml. PABA serum levels correlated significantly with chymotrypsin in stool. Compared with the conventional PABA test, since it is easily applicable in outpatients and the results are not influenced by medication or food.
在25例慢性外分泌性胰腺功能不全患者和37例对照中,对对氨基苯甲酸(PABA)试验与粪便中糜蛋白酶浓度进行了比较。另外16例患者的试验无法评估(比例为21%)。通过测定摄入N-苯甲酰-L-酪氨酰-PABA之前和之后1小时血清中的PABA水平,该试验可以缩短并简化:9例外分泌性胰腺功能不全患者的1小时血清水平为0.5±0.5纳摩尔/毫升,而8例对照为6.4±2.0纳摩尔/毫升。PABA血清水平与粪便中的糜蛋白酶显著相关。与传统的PABA试验相比,它易于在门诊患者中应用,且结果不受药物或食物的影响。